Point of care: Life-saving clinical trial technology at the crossroads

The fate of nations may depend upon the contributions of brave patients willing to risk their lives for treatments and vaccines. The technology that supports them, like almost everything else, has been ravaged by the pandemic.

“The only way out of this mess is for us to upend and rebuild the platforms that have failed us. From the top-down, from the bottom up, ‘end-to-end’ — whichever way works, saves the most lives and causes the least damage in the process. It is societal change, but we can no longer avoid it.”